Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAI FUDR with Dexamethasone for Unresectable Primary Liver Cancer
NCT00587067Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jun 2003
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of floxuridine in hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), sponsored by Memorial Sloan Kettering Cancer Center. Started Jun 2003; status: completed.
02
Drugs
floxuridine
03
Conditions
hepatocellular carcinoma (HCC)intrahepatic cholangiocarcinoma (ICC)
Beyond the preview
Go deeper on NCT00587067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00587067.